A new wave of research is showing what the old gym myths about stretching got wrong—and what you really need to do to reap its benefits.

A rare Homo habilis skeleton from Kenya reveals how early humans moved, climbed, and adapted more than two million years ago.

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

The symmetrical design and flexible fingers mean that the robot can transport objects on either side of its body. For humans, ...

A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...

PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...

A breakthrough method from the 1990s is now being transformed into an AI-powered tool to help doctors diagnose cerebral palsy ...

If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the submission of its clinical trial application (CTA) for Study SRP-1005-101, ...

Background: Primary coenzyme Q10 (CoQ10) deficiency is a rare, treatable mitochondrial disorder often caused by biallelic pathogenic variants in COQ8A gene (also known as ADCK3). It typically ...

For decades, the fitness industry has been running the same tired script on repeat. Move your body to shrink it. Sweat to earn food. Exercise until your jeans fit differently. And honestly? We are ...